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ChondrocyteThe role of Wnt signaling in osteoblastogenesis in the embryo remains to be fully established. Although β-
catenin, a multifunctional protein also mediating canonical Wnt signaling, is indispensable for embryonic os-
teoblast differentiation, the roles of the key Wnt co-receptors Lrp5 and Lrp6 are unclear. Indeed, global dele-
tion of either Lrp5 or Lrp6 did not overtly affect osteoblast differentiation in the mouse embryo. Here, we
generated mice lacking both receptors speciﬁcally in the embryonic mesenchyme and observed an absence
of osteoblasts in the embryo. In addition, the double-deﬁcient embryos developed supernumerary cartilage
elements in the zeugopod, revealing an important role for mesenchymal Lrp5/6 signaling in limb patterning.
Importantly, the phenotypes of the Lrp5/6 mutant closely resembled those of the β-catenin-deﬁcient embry-
os. These phenotypes are likely independent of any effect on the adherens junction, as deletion of α-catenin,
another component of the complex, did not cause similar defects. Thus, Lrp5 and 6 redundantly control em-
bryonic skeletal development, likely through β-catenin signaling.icine, Washington University
illiams@vai.org (B.O. Williams).
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The Wnt family of glycoproteins plays essential roles conserved
from ﬂies to humans in many developmental processes including
cell differentiation. In one mode of action, Wnt proteins engage
both the low-density lipoprotein receptor-related protein Lrp5 or 6,
and a member of the Frizzled receptor family, to activate an intracel-
lular signaling cascade that culminates in β-catenin-dependent tran-
scriptional regulation; this mechanism is commonly known as the
canonical pathway (Huelsken and Birchmeier, 2001; Mao et al.,
2001; Pinson et al., 2000; Tamai et al., 2000; Wehrli et al., 2000;
Wodarz and Nusse, 1998; Wu et al., 2008).
Genetic studies of Lrp5 have indicated a critical role forWnt signal-
ing in postnatal bone formation. LRP-5 was found to be inactivated in
patients with the osteoporosis-pseudoglioma syndrome (Gong et al.,
2001). Conversely, an activating mutation in LRP-5 has been linked
to patients with a high bone density syndrome (Boyden et al., 2002;
Little et al., 2002). Similarly, the Lrp5−/− mice developed a low bone
mass phenotype postnatally due to reduced osteoblast number andfunction (Kato et al., 2002), and Lrp5−/−; Lrp6+/− compound mu-
tants exhibited a further reduction in bone mass (Holmen et al.,
2004). Although Yadav et al. reported that Lrp5 controlled bone for-
mation indirectly through gut-derived serotonin (Yadav et al., 2008),
Cui et al. recently provided evidence that Lrp5 functioned directly in
the osteoblast lineage (Cui et al., 2011). Other proteins that participate
inWnt signaling have also been implicated in postnatal bone formation,
including the extracellular Wnt antagonist sclerostin (Balemans et al.,
2001, 2002; Brunkow et al., 2001; Li et al., 2008; Semenov et al.,
2005), and Wnt10b (Bennett et al., 2005).
Wnt signaling has also been implicated in osteoblast development
during embryogenesis. Loss ofWnt7b led to a delay in osteoblast differ-
entiation in the embryo (Tu et al., 2007). Deletion of β-catenin in the
embryonic mesenchyme resulted in a lack of mature osteoblasts in
the mouse embryo, due to the failure of progressing through the early
stages of differentiation, although deletion in the more mature osteo-
blast-lineage cells did not have a similar effect (Day et al., 2005; Glass
et al., 2005; Hill et al., 2005; Holmen et al., 2005; Hu et al., 2005;
Rodda and McMahon, 2006). However, because of the multiple func-
tions of β-catenin beyond Wnt signaling, it remains uncertain whether
the phenotype caused by β-catenin deletion faithfully reﬂects the role
of Wnt signaling during osteoblastogenesis.
Here we genetically deleted Lrp5 and 6, either singly or in combi-
nation, in the embryonic mesenchyme, and analyzed the skeletal phe-
notype. We further compared these mutants with embryos deﬁcient
223K.S. Joeng et al. / Developmental Biology 359 (2011) 222–229in either α-catenin- or β-catenin. The results provide evidence that
Lrp5 and Lrp6 redundantly mediate Wnt signaling to control both
osteoblastogenesis and cartilage development in the embryo.
Results
Deletion of either Lrp5 or 6 has little effect on embryonic skeleton
As a ﬁrst step to investigate the roles of Lrp5 and 6 in skeletogen-
esis, we generated Lrp5 and Lrp6 ﬂoxed alleles (Lrp5f and Lrp6f, re-
spectively) through homologous recombination (Fig. 1A, B). Mice
homozygous for either or both ﬂoxed alleles developed and repro-
duced normally, indicating that both alleles had a normal function.
We subsequently generated null alleles (Lrp5n or Lrp6n) from mice
harboring both the respective ﬂoxed allele and a germ-cell active
CMV-Cre transgene. Mice homozygous for Lrp5n appeared grossly
normal, but displayed low bone mass postnatally, as previously
reported (Kato et al., 2002) (data not shown). Embryos homozygous
for Lrp6 deletion in all cells (CMV-Cre; Lrp6f/f) died at birth with mul-
tiple developmental defects, recapitulating the phenotype previously
reported for Lrp6-deﬁcient embryos (Pinson et al., 2000) (Fig. 1C).
These results therefore validated our targeting strategy.
We next deleted Lrp6 speciﬁcally in the early mesenchyme, which
contain precursors for the skeletal tissues. Speciﬁcally, we used the
Dermo1-Cre strain to generate progenies with the genotype of either
Dermo1-Cre; Lrp6n/f or Dermo1-Cre; Lrp6f/f (6CKO) (Yu et al., 2003).
Mice of either genotype were born at the Mendelian ratio with no ob-
vious phenotype. Indeed, whole-mount skeletal staining of the 6CKOB 
A Exon 1 Exon 2 Exon 3 
Exon 1 Exon 2 Exon 3 
Exon 1 Exon 2 Exon 3 
Exon 1 Exon 2 Exon 3 
Exon 1 Exon 2 Exon 3 
Exon 1 Exon 2 Exon 3 
neo 
lox P lox P 
frt frt 













lox P lox P 
frt frt 












Fig. 1. Generation of mice deﬁcient in Lrp5 and/or Lrp6. (A) Gene targeting strategy for Lrp5
recognition target; LoxP: Cre recognition site; DT: diphtheria toxin expression cassette for n
cassette for negative selection. (C) Images of E18.5 littermate embryos with or without glob
bone area undermineralized in Dermo1Cre;Lrp6f/f (6CKO). (E) Photographs of wild type ver
mal skull and hindlimb morphology.embryo revealed a relatively normal skeleton, exhibiting only a slight
delay in ossiﬁcation of the skull at E17.5 (Fig. 1D). The relatively nor-
mal skeleton of the 6CKO embryonic skeleton was similar to that of
the Lrp5n/n (5KO) or the Dermo1Cre; Lrp5f/f (5CKO) embryo (Kato
et al., 2002) (data not shown). Thus, skeletal development proceeds
normally in embryos that lack either Lrp5 or Lrp6 in the skeletogenic
mesenchyme.
Loss of both Lrp5 and 6 causes profound skeletal defects in the embryo
We next deleted both Lrp5 and 6 in the embryonic mesenchyme. In
one approach, we generated embryos with the genotype of Der-
mo1Cre;Lrp5f/f;Lrp6f/f (5CKO6CKO), wherein deletion of Lrp5 and Lrp6
were both mediated by Dermo1-Cre. Anticipating that Cre-mediated re-
combination might be inefﬁcient, we also created mice of the genotype
Dermo1Cre;Lrp5n/n;Lrp6f/f (5KO6CKO) which lacked Lrp5 globally but
Lrp6 tissue-speciﬁcally. Embryos of either genotype developed to term
but died shortly after birth, exhibiting similar gross abnormalities in-
cluding reduced body size, misshaped skull and limbs (Fig. 1E).
Whole-mount skeletal staining conﬁrmed the shortening of all skeletal
elements, and revealed a profound defect in the ossiﬁcation of the cra-
niofacial, the rest of the axial and the appendicular skeleton (Fig. 2). In
addition, the sternum failed to fuse in themutant embryos of either ge-
notype, likely contributing to their neonatal lethality. Interestingly, both
mutant types displayed extra cartilage elements (typically 4) in the zeu-
gopod, and in some cases also in the autopod. However, whereas the
zeugopod elements in the 5KO6CKO embryo remained completely car-















. Neo: neomycin resistance gene expression cassette for positive selection; Frt: Flippase
egative selection. (B) Gene targeting strategy for Lrp6. TK: thymidine kinase expression
al deletion of Lrp6. (D) Whole-mouse skeletal staining at E17.5. Arrows denote frontal
sus Dermo1Cre;Lrp5f/f;Lrp6f/f (5CKO6CKO) littermates at E18.5. Arrows denote abnor-
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Fig. 2. Whole-mount skeletal staining of E18.5 embryos. Blue stains unmineralized cartilage, whereas red stains bone and mineralized cartilage. (A1–A4) Skull. mx: maxilla; md:
mandible; f: frontal bone; p: parietal bone. (B1–B4) Sternum. Arrows denote unfused sternum primordia. (C1–C4) Forelimb. (D1–D4) Hindlimb. a: autopod; z: zeugopod; s: sty-
lopod; sc: scapula. Red asterisks denote cartilage elements in zeugopod; black asterisk: additional digit; green arrow: ectopic cartilage. Note ossiﬁcation in scapula of all genotypes,
and in hindlimb zeugopod of 5CKO6CKO.
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5CKO6CKO embryo, although the scapula and the ileum were partially
ossiﬁed in bothmutants. Finally, the hindlimbs of the 5KO6CKOembryo
possessed an additional element bridging the zeugopod and the stylo-
pod. The discrepancies between the two genotypes likely reﬂected a
slight delay in sufﬁcient Lrp5/6 deletion, or a residual Lrp5/6 activity
in the 5CKO6CKO embryo, and prompted us to focus subsequent ana-
lyses on the 5KO6CKO mutant. Overall, these results indicate that Lrp5
and Lrp6 together control multiple aspects of skeletal development in






Fig. 3. Histology of the knee joint area in E18.5 embryos. f: femTo assess the relationship between Lrp5/6 and β-catenin in skeletal
development, we compared 5KO6CKO mutants with embryos of the
Dermo1Cre;β-cateninf/f genotype (βcatCKO). As previously reported,
the βcatCKO embryos exhibited shortening of all skeletal elements,
and a general lack of ossiﬁcation (except for the scapula and the
ileum), both features shared with the 5KO6CKO mutant (Fig. 2A4–
D4). Other commondefects between the twomutants included unfused
sterna and supernumerary cartilage elements in the limbs. Finally, his-
tological analyses revealed that both the 5KO6CKO and the βcatCKO






ur; t: tibia; *: ectopic cartilage. Arrows denote lack of joint.
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embryos exhibited very similar morphological defects in their skeleton.
Lrp5/6 signaling is indispensable for osteoblast differentiation
We next focused on the roles of Lrp5/6 in osteoblast differentia-
tion. H&E or picrosirius red/alcian blue staining of the humerus sec-
tions detected no obvious defect in either cartilage or bone in 5KO
or 6CKO embryos (Fig. 4A1–A4, B1–B4, C1–C4). On the other hand,
the 5CKO6CKO embryo exhibited a partial bone collar but no trabec-
ular bone (Fig. 4D1–D4), whereas the 5KO6CKO mutant possessed no
bone collar or trabecular bone (Fig. 4E1–E4). Moreover, in both
5CKO6CKO and 5KO6CKO embryos, the epiphyseal cartilage exhibited
abnormal morphology, and ectopic cartilage was present at the di-
aphysis (Fig. 4D1, E1). Particularly, in the 5KO6CKO embryo, ectopic
cartilage surrounded the entire marrow cavity (Fig. 4E3). Both the
lack of bone and the presence of ectopic cartilage were also observed
in the βcatCKO embryo, although here ectopic cartilage was often
seen to extend from the diaphyseal perichondrium into the marrow
cavity (Fig. 4F1–F4) (Hilton et al., 2005; Hu et al., 2005).
The absence of bone prompted us to assess the osteoblast lineage at
the molecular level by in situ hybridization. In E18.5 5KO6CKO embryos,







































Fig. 4. Histology of the humerus at E18.5. (A1–F1) H&E images at a lower magniﬁcation. (A
alcian blue staining at a lower magniﬁcation. (A4–F4) Boxed regions in (A3–F3) at a higher
stains bone matrix dark red whereas alcian blue stains cartilage matrix blue. Green arrows:
sumptive marrow cavity.osteoblast markers including Runx2 and alkaline phosphatase (AP), indi-
cating that the osteogenic programwas initiated (Fig. 5B1–B2). However,
osterix (Osx), a critical transcription factor downstream of Runx2, was
virtually absent, except in occasional small areas (Fig. 5B3). Importantly,
the mature osteoblast marker osteocalcin (OC) could not be detected in
the 5KO6CKO embryos (Fig. 5B4). This molecular proﬁle of the osteoblast
lineage was identical to that in the βcatCKO embryo (Fig. 5C1–C4) (Hu
et al., 2005). Thus, in both 5KO6CKO and βcatCKO embryos, mature oste-
oblasts failed to form likely due to the loss of Osx expression.
To gain further insight about Osx expression in themutant embryos,
we examined E14.5 and E15.5 embryos. Consistent with our previous
ﬁnding, Osx was either undetectable (E14.5) or barely (E15.5) detect-
able in the perichondrium of βcatCKO embryos (Fig. 6C3, E2) (Hu et
al., 2005). However, in the 5KO6CKO mutant the perichondral expres-
sion of Osx was relatively normal at E14.5 (Fig. 6B3). Thus, Osx expres-
sion appeared to initiate normally but failed to maintain in the
perichondrium in 5KO6CKOmutants. To explorewhether the initial ex-
pression of Osx could be attributed to residual Wnt signaling in the
5KO6CKO embryo, we examined the expression of Dkk1, a known tar-
get of canonical Wnt signaling in the perichondrium. Indeed, Dkk1
was detected in the perichondrium of the 5KO6CKO sample (Fig. 6B4),
but was completely absent in βcatCKO at both E14.5 and E15.5


















2–F2) Boxed regions in (A1–F1) at a higher magniﬁcation. (A3–F3) Picrosirius red and
magniﬁcation. c: bone collar; c*: partial bone collar; t: trabecular bone. Picrosirius red































Fig. 5. In situ hybridization of osteoblast markers at E18.5. Signal is in red. Arrow denotes occasional Osx signal; asterisks: Osx signal in ectopic cartilage.
226 K.S. Joeng et al. / Developmental Biology 359 (2011) 222–229to be required for both initiation and maintenance of Osx expression
(but see discussion).
Lrp5/6 signaling promotes chondrocyte hypertrophy
The severe shortening of the endochondral skeletal elements in the
Lrp5/6-deﬁcient embryos indicated that growth of the cartilage anlagen
was likely defective. We therefore examined the status of chondrocyte
hypertrophy, a major driving force for skeletal linear growth. In the hu-
merus, a distinct zone of hypertrophy normally emerges around E14.5,
and this event was undisturbed in the 5KO embryo, as conﬁrmed by
both histology and in situ hybridization of Col10a1, a speciﬁc marker for
hypertrophic chondrocytes (Fig. 7A1–A3). However, in the 5KO6CKO lit-































Fig. 6. In situ hybridization. 5KO embryos used a normal controls for E14.5 samples. Amorphologically, and the expression domain of Col10a1 was greatly re-
duced (Fig. 7B1–B3), indicating a marked delay in chondrocyte hypertro-
phy. The delaywas reminiscent of, but slightly less severe than that in the
βcatCKO mutant (Hu et al., 2005). Indeed, in the βcatCKO embryo, there
was little sign of cellular hypertrophy even at E15 when a hypertrophic
zone was normally fully developed in the humerus, consistent with the
very limited expression of Col10a1 in the mutant (Fig. 7C1–C3, D1–D3).
Thus, loss of Lrp5/6 signaling resulted in a marked delay in chondrocyte
hypertrophy that was similar to that caused by β-catenin deﬁciency.
Deletion of α-catenin has little effect on embryonic skeleton
To discern the potential role of the adherens junction on skeletal






















































Fig. 7. Analyses of chondrocyte hypertrophy. (A1–D1) H&E at a lower magniﬁcation. (A2–D2) Boxed regions in (A1–D1) at a higher magniﬁcation. (A3–D3) In situ hybridization of
Col10a1. H: hypertrophic zone; *: emerging hypertrophic cells.
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normal. A careful examination of the E18.5 skeleton revealed only a
minor delay in ossiﬁcation in the skull, and a slight shortening of
the bone collar in the long bones (Fig. 8A). Histological analyses
showed that formation of the marrow cavity appeared to be slightly
delayed in the tibia (Fig. 8B). Overall, loss of α-catenin in the limb
mesenchyme, in contrast to that of β-catenin, had minimal effects
on skeletal development.
Discussion
By employing genetic deletion of Lrp5 and 6 either singly or in
combination, we have established that the two receptors together
are indispensable for normal skeletal development in the embryo.
The double mutant embryos exhibited a multitude of skeletal de-
fects affecting bone, cartilage and the joints. These ﬁndings are
not only consistent with the expression of multiple Wnt ligands in the
developing skeleton, but more importantly, they recapitulate many
phenotypes of the β-catenin-deﬁcient embryos. Therefore, the current
results support the concept that canonical Wnt signaling critically con-
trols skeletal development during embryogenesis.
We have focused on the role of Lrp5/6 and β-catenin in osteo-
blast differentiation. Mice lacking either component failed to pro-
duce mature osteoblasts, likely due to the loss of Osx expression.
However, a temporal analysis revealed a clear difference between
the two mutants. Whereas the β-catenin mutant never initiated a
strong Osx expression in the perichondrium, the Lrp5/6 embryos
appeared to express Osx normally at E14.5 but failed to maintain
it at later stages. This discrepancy could be explained by incom-
plete deletion of Lrp5/6 at E14.5, as Dkk1, a known target of ca-
nonical Wnt signaling (Chamorro et al., 2005; Niida et al., 2004),was still detectable in the perichondrium of these but not the β-
catenin embryos. Thus, canonical Wnt signaling through Lrp5/6
and β-catenin could be necessary for both initiation and mainte-
nance of Osx expression, although the data do not exclude that
β-catenin may control Osx initiation independently of Lrp5/6.
Moreover, a role for β-catenin in Osx maintenance remains to be
formally examined, even though β-catenin is necessary for further
differentiation of Osx-positive cells (Rodda and McMahon, 2006).
Whatever the exact relationship between Lrp5/6 and β-catenin
in regulating Osx expression, the current study clearly establishes
that Lrp5/6 signaling is indispensable for the formation of mature
osteoblasts.
Our study also demonstrates a clear role for Lrp5 in osteoblast dif-
ferentiation. Such a role has been a matter of debate, because Lrp5n/n
mice exhibit normal embryonic bone development, and a deﬁcit in
bone mass becomes apparent only later in life (Kato et al., 2002).
Moreover, a recent study proposed that Lrp5 affected bone mass indi-
rectly through action in the gut, challenging the role of direct Wnt/
Lrp5 signaling in bone (Yadav et al., 2008). We now show that where-
as deletion of either Lrp5 or Lrp6 in the skeletogenic mesenchyme
caused no obvious defect, a result consistent with what was previous-
ly reported for Lrp5 (Yadav et al., 2010), deletion of both abolished
the formation of mature osteoblasts. Although a more severe pheno-
type was observed in embryos with Lrp5 global and Lrp6 tissue-spe-
ciﬁc deletion, a marked defect was also evident in embryos
containing tissue-speciﬁc deletions of both genes. The discrepancy
in severity between the two types of mutants was likely due to poten-
tial differences in the efﬁciency or timing of Cre-mediated recombina-
tion (two versus four ﬂoxed alleles). Overall, the results provide
strong evidence that Lrp5 is required for osteoblast differentiation
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Fig. 8. Analyses of the α-catenin CKO embryos at E18.5. (A) Whole-mount skeletal preparations. Arrows denote delay in mineralization of skull in α-catenin CKO mutant; asterisks
indicate slight shortening of bone collar in the mutant. (B) Histology of the tibia. Boxed regions shown at a higher magniﬁcation to the right. Arrow denotes more abundant myeloid
cells present in the wild type bone marrow.
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etal patterning of the limb. In both 5CKO6CKO and 5KO6CKO embryos,
supernumerary cartilage elements were observed in the limbs, a pheno-
type also seen in the βcatCKO mutants. Interestingly, we previously ob-
served that Lrp5+/−;Lrp6+/− or Lrp5−/−;Lrp6+/− mice also exhibited
limb patterning defects, with mice often missing digits (Holmen et al.,
2004). Similarly, others have reported that the Lrp6−/− embryos had
fewer skeletal elements in both zeugopod and autopod (Collette et al.,
2010). The discrepancy in phenotype between the previous and the pre-
sent mutants may reﬂect the difference between global (both ectoderm
andmesenchyme of the limb) versusmesenchyme-speciﬁc deﬁciency of
Lrp5/6 signaling. Overall, Lrp5/6 and β-catenin signaling in the limbmes-




Mouse strains of Dermo1-Cre or β-cateninf/f are as previously de-
scribed (Brault et al., 2001; Yu et al., 2003). Embryos of Dermo1-
Cre;β-cateninf/f were generated as previously described (Hu et al.,
2005). The ﬂoxed alleles for Lrp5 and Lrp6 were generated using ho-
mologous recombination in CJ7 embryonic stem (ES) cell (Swiatek
and Gridley, 1993). The Lrp5 targeting vector consisted of a 3.8 kb
5′ region of homology (ROH) containing genomic DNA from intron
1 of Lrp5 and a 1.9 kb 3′ ROH within intron 2. LoxP sites were placed
around exon 2 of Lrp5. For clone selections, an frt-ﬂanked neomycin
selection cassette in reverse orientation was included before the 3′
ROH and a Diphtheria toxin selection cassette was placed after the
3′ ROH. The Lrp6 targeting vector consisted of a 2.9 kb 5′ ROHcontaining genomic DNA from intron 1 of Lrp6 and a 3.0 kb 3′ ROH
within intron 2 of Lrp6. LoxP sites were placed around exon 2 of
Lrp6. An frt-ﬂanked neomycin selection cassette was included just
before the 3′ ROH for positive selection, and a TK cassette was placed
after the 3′ ROH for negative selection.Mouse embryo analyses
Whole-mount skeletal staining of embryos was performed accord-
ing to McLeod with modiﬁcations (McLeod, 1980). For sections of
E14.5 and E15.5 embryos, tissues were collected in PBS, ﬁxed in 10%
Formalin overnight at room temperature, then processed and embed-
ded in parafﬁn prior to sectioning at 6 μm. For sections of E17.5 and
E18.5 embryos, limbs were decalciﬁed in 14% EDTA in PBS, pH 7.4
for 48 h after ﬁxation and prior to processing. In situ hybridization
was performed as described previously by using 35S-labeled ribop-
robes (Long et al., 2001). All in situ probes were as previously de-
scribed (Hu et al., 2005; Joeng and Long, 2009; Long et al., 2001,
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